Search results
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 6 days agoBut after cutting his teeth at Big Pharma stalwarts, including Takeda Pharmaceutical and AstraZeneca...
The WHO’s naive global vaccine plan won’t withstand contact with reality
The Telegraph via Yahoo News· 7 days agoThe AstraZeneca vaccine was, for a while, the most celebrated product in Britain. The UK was one of...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
The Motley Fool via AOL· 4 days agoInstead of investing in Johnson & Johnson, I suggest you consider a better and safer investment in ...
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
Reuters· 4 days agoLeading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France...
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France By Reuters
Investing.com· 4 days agoLeading healthcare companies Pfizer (NYSE:PFE) and AstraZeneca (NASDAQ:AZN) announced on Sunday new...
AstraZeneca Pulls Covid Shot due to Low Demand
Erie News Now Plus· 3 days agoUK based drug-maker, AstraZeneca, is pulling its covid-19 vaccine from global markets due to low demand
Microsoft, Amazon and AstraZeneca invest billions in France By Proactive Investors
Investing.com· 3 days agoMicrosoft, Amazon and AstraZeneca invest billions in France
Med-tech of China gaining popularity
China Daily· 1 day agoA large proportion of the business in these areas is in overseas markets, said Leon Wang, executive vice-president, international and China unit president at AstraZeneca, ...
The Petri Dish: Nabla Bio nabs $26M, X4 gets capital infusion - Boston Business Journal
The Business Journals· 7 hours agoThis week's Petri Dish explores more than one way biotech's can raise funds. Nabla Bio recently...
Wednesday's Health Report: Astrazeneca pulling COVID-19 vaccine, cites low demand
WBRZ 2 Baton Rouge· 6 days agoBATON ROUGE — U.K.-based drug manufacturer Astrazeneca is pulling its COVID-19 vaccine globally. They cited low demand. The company said the vaccine has not generated revenue ...